The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To demonstrate the effects of tegaserod on gastrointestinal scintigraphic orocecal transit in
female patients with CC and upper GI symptoms of dyspepsia